Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph Node Dissection for Breast Cancer Treatment

  • 0Section of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

|

|

Summary

This summary is machine-generated.

Immediate lymphatic reconstruction (ILR) and younger age are protective factors for normal lymphatic function after axillary lymph node dissection (ALND) for breast cancer. These findings suggest ILR may prevent lymphedema development.

Area Of Science

  • Oncology
  • Surgical Oncology
  • Lymphedema Research

Background

  • Axillary lymph node dissection (ALND) for breast cancer treatment carries a risk of lymphedema.
  • Lymphedema diagnosis criteria are often arbitrary and inconsistent across studies.
  • This research focuses on identifying protective factors for lymphatic function post-ALND.

Purpose Of The Study

  • To identify factors associated with preserved lymphatic function after ALND in breast cancer patients.
  • To investigate the role of immediate lymphatic reconstruction (ILR) in maintaining lymphatic function.
  • To determine the impact of patient age on lymphatic function after ALND.

Main Methods

  • Prospective study of 150 women undergoing unilateral ALND for breast cancer (2020-2023).
  • Normal lymphatic function defined by <10% arm volume change, <10 bioimpedance change, no compression use, and Stage 0 ICG lymphography at 1-year follow-up.
  • Univariable and multivariable logistic regression analyses were employed.

Main Results

  • 26% of patients (39/150) exhibited normal lymphatic function at 1 year.
  • Immediate lymphatic reconstruction (ILR) was significantly associated with normal lymphatic function (OR = 2.79, p=0.017).
  • Younger age was also significantly associated with normal lymphatic function (OR = 0.93, p=0.001).

Conclusions

  • Immediate lymphatic reconstruction (ILR) and younger patient age are key protective factors for lymphatic function post-ALND.
  • These findings indicate that ILR may serve as a preventative measure against breast cancer-related lymphedema.
  • Further research into ILR's role in mitigating lymphedema is warranted.